|1.||Murakami, Takamichi: 13 articles (02/2015 - 04/2007)|
|2.||Ito, Katsuyoshi: 11 articles (06/2015 - 03/2010)|
|3.||Matsui, Osamu: 10 articles (10/2015 - 03/2011)|
|4.||Kanki, Akihiko: 10 articles (06/2015 - 03/2010)|
|5.||Tamada, Tsutomu: 10 articles (06/2015 - 03/2010)|
|6.||Kudo, Masatoshi: 9 articles (10/2015 - 01/2009)|
|7.||Higaki, Atsushi: 9 articles (06/2015 - 12/2011)|
|8.||Okada, Masahiro: 8 articles (02/2015 - 04/2007)|
|9.||Higashi, Hiroki: 8 articles (10/2013 - 03/2010)|
|10.||Sato, Tomohiro: 7 articles (06/2015 - 12/2011)|
|1.||Neoplasm Metastasis (Metastasis)
07/01/2012 - "Combining DW-MRI with Gd-EOB-DTPA-enhanced T(1) weighted MRI significantly improved the detection of colorectal liver metastases."
06/01/2015 - "This retrospective study was to investigate whether adding diffusion-weighted imaging (DWI) to Gd-EOB-DTPA-enhanced MRI (EOB-MRI) improved the detection of liver metastasis in radiology resident and board-certified radiologist groups. "
07/01/2012 - "Using combined image set improved identification of liver metastases compared with Gd-EOB-DTPA image set (p<0.001) or DW-MRI image set (p<0.001). "
02/01/2012 - "This study was performed to assess the role of retrospective PET-MRI fusion with Ga-68-DOTA(0)-Phe(1)-Tyr(3)-octreotide (Ga-68-DOTATOC) PET and Gd-EOB-DTPA MRI in the detection of hepatic metastases from neuroendocrine tumours (NET). "
05/01/2005 - "This study showed that interstitial MR lymphography with Gd-EOB-DTPA can detect metastasis and that the optimal dose in rabbits is 8 micromol Gd/kg as a subcutaneous application."
|2.||Hepatocellular Carcinoma (Hepatoma)
01/01/2012 - "Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma."
12/01/2014 - "Magnetic resonance imaging with gadoxetic acid disodium for the detection of hepatocellular carcinoma: a meta-analysis of 18 studies."
11/01/2012 - "The purpose of this study was to elucidate the incidence and risk factors for the progression of hypointense nodules observed in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-enhanced MRI) of hypervascular hepatocellular carcinoma (HCC). "
12/01/2011 - "The aim of this study was to reveal the relationship between intratumoral uptake of gadoliniumethoxylbenzyldiethylenetriaminepentaacetic acid (Gd-EOB-DTPA) of hepatocellular carcinoma (HCC) in the hepatobiliary phase and pathological features. "
10/01/2009 - "Based on published clinical trials and the experience of the attendees in the use of Gd-EOB-DTPA in liver imaging, a new simplified, non-invasive diagnostic algorithm was proposed that would be applicable to both Eastern and Western clinical practice in the evaluation of hepatocarcinogenesis and hepatocellular carcinoma. "
06/15/2007 - "The use of gadoxetic acid disodium, a hepatocyte-specific contrast agent with prolonged retention, is described as a method of improved assessment of the ablative margins relative to the tumor margins."
01/01/2011 - "Gd-EOB-DTPA-enhanced T1-weighted imaging is helpful in the detection of hepatic tumors in H-ras 12V TG mice."
12/01/2015 - "The aim of this study was to investigate the feasibility of ablative margin (AM) grading by magnetic resonance imaging (MRI) with Gd-EOB-DTPA administered prior to radiofrequency ablation (RFA), and to identify factors for achieving a sufficient AM and predictors for local tumor progression. "
09/01/2010 - "This study included nine patients with nine histopathologically proven HCCs (mean size, 1.9 cm) that consisted of two portions of a non-hypointense (Gd-EOB-DTPA uptake) and hypointense area (no Gd-EOB-DTPA uptake) in one tumor as depicted on hepatobiliary-phase MR images. "
07/07/2015 - "Gd-EOB-DTPA-enhanced MRI in one case clearly showed a low-signal tumor in the hepatobiliary phase, similar to what was seen by positron emission tomography-CT. "
|4.||Liver Diseases (Liver Disease)
07/01/2015 - "Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors."
02/01/2011 - "The results of our study demonstrate that the presence of chronic liver disease significantly affects the signal intensity of the bile duct in Gd-EOB-DTPA-enhanced MR imaging. "
11/01/2010 - "The purpose of this study was to describe magnetic resonance (MR) findings of focal eosinophilic liver disease using gadoxetic acid (Gd-EOB-DTPA). "
07/01/1992 - "In this study, Gd-EOB-DTPA was evaluated in a rodent model of metastatic liver disease to measure both relative enhancement and lesion-to-liver contrast. "
10/01/2015 - "Gd-EOB-DTPA-enhanced MRI may provide a useful detection method for liver disease in patients with LC-PBC."
01/01/2015 - "Strong correlations of the uptake characteristics of Gd-EOB-DTPA with the relative enhancement (RE) of the liver parenchyma and the grade of fibrosis/cirrhosis, classified using the Ishak scoring system, were observed. "
07/17/2014 - "Hepatocyte phase RCEI values obtained with Gd-EOB-DTPA-enhanced MRI scan indicate liver injury in hepatic fibrosis and early cirrhosis. "
07/17/2014 - "To evaluate the hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the early diagnosis of hepatic fibrosis and cirrhosis and assessment of liver function in a rat model. "
02/25/2014 - "Hepatobiliary phase imaging may improve the diagnostic confidence and sensitivity of GD-EOB-DTPA for HCC in cirrhosis."
06/01/2013 - "Primovist-enhanced MRI is very accurate in the identification of HCC in cirrhosis, especially if the tumour is greater than 17 mm and undifferentiated. "
|2.||Pentetic Acid (DTPA)
|4.||Gadolinium DTPA (Magnevist)
|6.||Acetic Acid (Vinegar)
|8.||gadolinium ethoxybenzyl DTPA
|10.||gadobenic acid (gadobenate dimeglumine)
|2.||Drug Therapy (Chemotherapy)